Novo Integrated Sciences Debt to Equity Ratio 2012-2024 | NVOS
Current and historical debt to equity ratio values for Novo Integrated Sciences (NVOS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Novo Integrated Sciences debt/equity for the three months ending February 29, 2024 was 0.00.
| Novo Integrated Sciences Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-02-29 |
$0.01B |
$0.02B |
0.60 |
| 2023-11-30 |
$0.01B |
$0.02B |
0.60 |
| 2023-08-31 |
$0.01B |
$0.02B |
0.45 |
| 2023-05-31 |
$0.01B |
$0.03B |
0.36 |
| 2023-02-28 |
$0.01B |
$0.03B |
0.35 |
| 2022-11-30 |
$0.02B |
$0.02B |
0.83 |
| 2022-08-31 |
$0.02B |
$0.02B |
0.85 |
| 2022-05-31 |
$0.03B |
$0.04B |
0.62 |
| 2022-02-28 |
$0.03B |
$0.05B |
0.58 |
| 2021-11-30 |
$0.02B |
$0.04B |
0.46 |
| 2021-08-31 |
$0.02B |
$0.04B |
0.41 |
| 2021-05-31 |
$0.01B |
$0.04B |
0.15 |
| 2021-02-28 |
$0.01B |
$0.03B |
0.20 |
| 2020-11-30 |
$0.01B |
$0.03B |
0.20 |
| 2020-08-31 |
$0.01B |
$0.03B |
0.20 |
| 2020-05-31 |
$0.01B |
$0.03B |
0.20 |
| 2020-02-29 |
$0.01B |
$0.03B |
0.21 |
| 2019-11-30 |
$0.01B |
$0.03B |
0.26 |
| 2019-08-31 |
$0.01B |
$0.03B |
0.26 |
| 2019-05-31 |
$0.01B |
$0.03B |
0.25 |
| 2019-02-28 |
$0.00B |
$0.03B |
0.17 |
| 2018-11-30 |
$0.01B |
$0.00B |
8.78 |
| 2018-08-31 |
$0.01B |
$0.00B |
26.45 |
| 2018-05-31 |
$0.01B |
$0.00B |
16.06 |
| 2018-02-28 |
$0.01B |
$0.00B |
13.36 |
| 2017-11-30 |
$0.01B |
$-0.00B |
-2.13 |
| 2017-08-31 |
$0.01B |
$-0.00B |
-2.29 |
| 2017-05-31 |
$0.01B |
$-0.01B |
-2.19 |
| 2017-03-31 |
$0.00B |
$0.00B |
0.17 |
| 2017-02-28 |
$0.00B |
|
0.00 |
| 2016-12-31 |
$0.00B |
|
0.00 |
| 2016-11-30 |
$0.00B |
|
0.00 |
| 2016-09-30 |
$0.00B |
$0.00B |
0.13 |
| 2016-06-30 |
$0.00B |
$0.00B |
0.43 |
| 2016-05-31 |
$0.00B |
|
0.00 |
| 2016-03-31 |
$0.00B |
$0.00B |
1.31 |
| 2015-12-31 |
$0.00B |
|
0.00 |
| 2015-09-30 |
$0.00B |
$0.00B |
1.14 |
| 2015-06-30 |
$0.00B |
$0.00B |
-1.65 |
| 2015-03-31 |
$0.00B |
$0.00B |
-1.40 |
| 2014-12-31 |
$0.00B |
|
0.00 |
| 2014-09-30 |
$0.00B |
$-0.00B |
-1.23 |
| 2014-06-30 |
$0.00B |
$-0.00B |
-1.18 |
| 2014-03-31 |
$0.00B |
$-0.00B |
-1.32 |
| 2013-12-31 |
$0.00B |
|
0.00 |
| 2013-09-30 |
$0.00B |
$-0.00B |
-1.43 |
| 2013-06-30 |
$0.00B |
$-0.00B |
-1.02 |
| 2013-03-31 |
$0.00B |
$-0.00B |
-1.05 |
| 2012-12-31 |
$0.00B |
$-0.00B |
-1.04 |
| 2012-09-30 |
$0.00B |
$-0.00B |
-1.53 |
| 2012-08-31 |
$0.00B |
|
0.00 |
| 2012-06-30 |
$0.00B |
$0.00B |
-1.68 |
| 2012-03-31 |
$0.00B |
$-0.00B |
-1.12 |
| 2012-02-29 |
$0.00B |
$0.00B |
0.00 |
| 2011-12-31 |
$0.00B |
$-0.00B |
-1.01 |
| 2011-11-30 |
$0.00B |
|
0.00 |
| 2011-09-30 |
$0.00B |
|
0.00 |
| 2011-08-31 |
$0.00B |
$0.00B |
0.00 |
| 2011-06-30 |
$0.00B |
|
0.00 |
| 2011-05-31 |
$0.00B |
$0.00B |
0.00 |
| 2011-03-31 |
$0.00B |
|
0.00 |
| 2011-02-28 |
$0.00B |
$0.00B |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.010B |
$0.013B |
|
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
|
